Tassaneeyakul W, Birkett D J, McManus M E, Tassaneeyakul W, Veronese M E, Andersson T, Tukey R H, Miners J O
Department of Clinical Pharmacology, Flinders Medical Centre, Bedford Park, SA, Australia.
Biochem Pharmacol. 1994 May 18;47(10):1767-76. doi: 10.1016/0006-2952(94)90304-2.
Caffeine (CA) N1-, N3- and N7-demethylase, CA 8-hydroxylase and phenacetin O-deethylase activities were measured in microsomes from 18 separate human livers which had been characterized previously for a range of cytochrome P450 (CYP) isoform-specific activities and immunoreactive CYP protein contents. Correlations between the high affinity components of the three separate CA N-demethylations were highly significant (r = 0.77-0.91, P < 0.001) and each of the three high affinity CA N-demethylations correlated significantly (r = 0.64-0.93, P < 0.05-0.001) with the high affinity phenacetin O-deethylase, 2-acetylaminofluorene N-hydroxylation and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) mutagenicity (all predominantly CYP1A2-mediated reactions). Consistent with these observations, cDNA-expressed human CYP1A2 catalyzed the N1-, N3- and N7-demethylation of CA and apparent Km values were similar (0.24-0.28 mM) for all three reactions and comparable to those observed previously with human liver microsomes. The low affinity components of CA N1- and N7-demethylation correlated significantly (r = 0.55-0.85, P < 0.05-0.001) with immunoreactive CYP2E1 content and the CYP2E1-specific activities 4-nitrophenol and chlorzoxazone hydroxylation. Diethyldithiocarbamate, a selective inhibitor of CYP2E1, inhibited the low affinity CA N1- and N7-demethylation, with IC50 values of 23 microM and 11 microM, respectively. The apparent Km values for CA N1- and N7-demethylation by cDNA-expressed CYP2E1 (namely 28 and 43 mM, respectively) were of a similar order to those calculated for the low affinity microsomal activities. Significant correlations (r = 0.87-0.97, P < 0.001) were observed between CA 8-hydroxylation and immunoreactive CYP3A content and the CYP3A-mediated reactions benzo(a)pyrene hydroxylation, omeprazole sulfoxidation and aflatoxin B1 mutagenesis. Effects of alpha-naphthoflavone, erythromycin, troleandomycin and nifedipine on microsomal CA 8-hydroxylation were generally consistent with CYP3A involvement. Taken together with previous data, the results indicate a major involvement of CYP1A2 in the high affinity component of all three human hepatic CA N-demethylations. In contrast, CYP2E1 appears to be the main enzyme involved in the low affinity components of CA N1- and N7-demethylation while CA 8-hydroxylation is catalysed predominantly by a CYP3A isoform(s).
在来自18个不同人肝脏的微粒体中测量了咖啡因(CA)的N1-、N3-和N7-去甲基酶活性、CA 8-羟化酶活性以及非那西丁O-脱乙基酶活性。这些肝脏先前已针对一系列细胞色素P450(CYP)同工型特异性活性和免疫反应性CYP蛋白含量进行了表征。三种不同的CA N-去甲基化的高亲和力组分之间的相关性非常显著(r = 0.77 - 0.91,P < 0.001),并且三种高亲和力CA N-去甲基化中的每一种都与高亲和力非那西丁O-脱乙基酶、2-乙酰氨基芴N-羟化以及2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶(PhIP)和2-氨基-3-甲基咪唑并[4,5-f]喹啉(IQ)的致突变性显著相关(所有这些主要是CYP1A2介导的反应)(r = 0.64 - 0.93,P < 0.05 - 0.001)。与这些观察结果一致,cDNA表达的人CYP1A2催化了CA的N1-、N3-和N7-去甲基化,并且所有三种反应的表观Km值相似(0.24 - 0.28 mM),与先前用人肝微粒体观察到的值相当。CA N1-和N7-去甲基化的低亲和力组分与免疫反应性CYP2E1含量以及CYP2E1特异性活性4-硝基苯酚和氯唑沙宗羟化显著相关(r = 0.55 - 0.85,P < 0.05 - 0.001)。二乙基二硫代氨基甲酸盐,一种CYP2E1的选择性抑制剂,抑制了低亲和力的CA N1-和N7-去甲基化,IC50值分别为23 microM和11 microM。cDNA表达的CYP2E1对CA N1-和N7-去甲基化的值(分别为28和43 mM)与为低亲和力微粒体活性计算的值处于相似的数量级。在CA 8-羟化与免疫反应性CYP3A含量以及CYP3A介导的反应苯并(a)芘羟化、奥美拉唑硫氧化和黄曲霉毒素B1致突变性之间观察到显著相关性(r = 0.87 - 0.97,P < 0.001)。α-萘黄酮、红霉素、醋竹桃霉素和硝苯地平对微粒体CA 8-羟化的影响总体上与CYP3A的参与一致。与先前的数据一起,结果表明CYP1A2在所有三种人肝CA N-去甲基化的高亲和力组分中起主要作用。相比之下,CYP2E1似乎是参与CA N1-和N7-去甲基化低亲和力组分的主要酶,而CA 8-羟化主要由一种CYP3A同工型催化。